英语释义

• myeloma that develops in several places at the same time

片语

indolent multiple myeloma惰性骨髓瘤

multiple myeloma related nephropathy多发性骨髓瘤病肾病

multiple myeloma patients多发性骨髓瘤

multiple myeloma cell多发性骨髓瘤细胞

multiple myeloma mm patients多发性骨髓瘤

multiple myeloma nephropathy骨髓瘤肾病

Multiple myeloma and osteoporosis第五节

senile multiple myeloma老年人多发性骨髓瘤

multiple e myeloma多发性骨髓瘤

英汉例句

• research funded by the multiple myeloma re--search foundation at a small biotech led to a promising new drug for multiple myeloma, a cancer of plasma cells in bones.

  multiple myeloma研究基金会资助了一家小型生物科技企业的研究，发现了一种很有前途的新药，能够治疗多发性骨髓瘤，一种骨头中原生质细胞的癌癥。

• purpose: lenalidomide is a novel therapeutic agent with uncertain mechanism of action that is clinically active in myelodysplastic syndrome (mds) and multiple myeloma (mm).

  目的：来那度胺是一种机理未明但临床上对骨髓增生异常综合癥及多发性骨髓瘤又确定疗效的新药。

• at low power, the abnormal plasma cells of multiple myeloma fill the marrow.

  低倍镜显示多发性骨髓瘤异常浆细胞弥漫浸润骨髓。

• conclusion: ibandronate can effectively relieve bone pain caused by multiple myeloma and drop serum calcium, to treat hypercalcemia .

  结论：伊班膦酸钠能有效缓解多发性骨髓瘤患者骨痛，降低血钙，治疗高钙血癥。

• george vlasuk, chief executive of sirtris, said in a phone interview that the complication is common in multiple myeloma patients and 「may or may not be related to」 the drug.

  sirtris的首席执行官georgevlasuk在一个电话采访中说并发癥对于多发性骨髓瘤很普遍，「可能会也可能不会」是和药物有关。

• 「we found a predominance of multiple myeloma in younger folks than we would have expected, 」 said dr. jacqueline moline, the study's author.

  这个研究的作者jacquelinemoline说：“我们发现，在年轻的患者中，多发性骨髓瘤癌的发展程度超过了我们的预期。

• objective to analyse clinical characteristics of multiple myeloma (mm).

  目的探讨多发性骨髓瘤的临床特征。

• methods the data of 65 patients with multiple myeloma at the first visit were analysed.

  方法复习65例多发性骨髓瘤患者初诊时的临床资料。

• the cystic fibrosis foundation has revolutionized the way drugs for rare diseases are developed and the multiple myeloma research foundation has helped change the way that blood cancer is treated.

  囊性纤维化基金会（cysticfibrosisfoundation）使罕见疾病药物的开发方式发生了变革，多发性骨髓瘤研究基金会（multiple myelomaresearchfoundation）已经帮助医生改变了血癌的治疗方法。

• aim: to search for different x and ct appearances of thoracic bone invasion between multiple myeloma (mm) and tumor of bone metastasis (bm).

  目的：探讨多发性骨髓瘤（mm）与骨转移瘤（bm）胸部骨骼受侵的x线及ct所见的不同。

• the researchers deployed a combination of peptides—small pieces of protein—that are known to be specific to multiple myeloma cells and are important for their survival.

  这些研究人员将肽（蛋白质片段）化合物作为研究重点，该化合物为多发性骨髓瘤细胞所独有，对于这种细胞的生存至关重要。

• it found a small but inordinate number of multiple myeloma cases among responders under age 45.

  那个案例中发现很小，但不正常数量的多发性肿瘤存在于45岁以下人员中。

• revlimid, which is approved for multiple myeloma patients in combination with the steroid dexamethasone, and for a rare condition called myelodysplastic syndromes, had revenue of $1.7 billion in 2009.

  revlimid和类固醇地塞米松联合用药被批準用于多发性脊髓瘤和罕见病骨髓增生异常综合征 的治疗。其2009年的销售额为17亿美元。

• the lesson to be learned from the present case is that a transient plasma cell dyscrasia may present like multiple myeloma in the setting of heavy immunosuppression after organ transplantation.

  从这个病例中得到的教训是，在器官移植后的严重免疫抑制状况下，暂时性血细胞恶液质可以有类似多发性骨髓瘤样的表现。

• multiple myeloma is a blood cancer that typically strikes much later in life.

  多发性肿瘤是一种血癌，通常在晚期才发作。